Combined Detection of Serum IL-10, IL-17, and CXCL10 Predicts Acute Rejection Following Adult Liver Transplantation

  • Kim, Nayoung (Department of Convergence Medicine & Asan Institute for Life Sciences) ;
  • Yoon, Young-In (Division of Liver Transplantation and Hepatobiliary Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Yoo, Hyun Ju (Department of Convergence Medicine & Asan Institute for Life Sciences) ;
  • Tak, Eunyoung (Department of Convergence Medicine & Asan Institute for Life Sciences) ;
  • Ahn, Chul-Soo (Division of Liver Transplantation and Hepatobiliary Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Song, Gi-Won (Division of Liver Transplantation and Hepatobiliary Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Lee, Sung-Gyu (Division of Liver Transplantation and Hepatobiliary Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Hwang, Shin (Division of Liver Transplantation and Hepatobiliary Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine)
  • Received : 2016.05.26
  • Accepted : 2016.07.20
  • Published : 2016.08.31


Discovery of non-invasive diagnostic and predictive biomarkers for acute rejection in liver transplant patients would help to ensure the preservation of liver function in the graft, eventually contributing to improved graft and patient survival. We evaluated selected cytokines and chemokines in the sera from liver transplant patients as potential biomarkers for acute rejection, and found that the combined detection of IL-10, IL-17, and CXCL10 at 1-2 weeks post-operation could predict acute rejection following adult liver transplantation with 97% specificity and 94% sensitivity.


Supported by : National Research Foundation of Korea (NRF), Asan Institute for Life Sciences, Asan Medical Center


  1. Berres, M.L., Trautwein, C., Schmeding, M., Eurich, D., Tacke, F., Bahra, M., Neuhaus, P., Neumann, U.P., and Wasmuth, H.E. (2011). Serum chemokine CXC ligand 10 (CXCL10) predicts fibrosis progression after liver transplantation for hepatitis C infection. Hepatology 53, 596-603.
  2. Boix-Giner, F., Millan, O., San Segundo, D., Munoz-Cacho, P., Mancebo, E., Llorente, S., Rafael-Valdivia, L., Rimola, A., Fabrega, E., Mrowiec, A., et al. (2016). High frequency of central memory regulatory T cells allows detection of liver recipients at risk of early acute rejection within the first month after transplantation. Int. Immunol. 28, 55-64.
  3. Capece, T., and Kim, M. (2016). The role of lymphatic Niches in T cell differentiation. Mol. Cells 39, 515-523
  4. Fabrega, E., Lopez-Hoyos, M., San Segundo, D., Casafont, F., and Pons-Romero, F. (2009). Changes in the serum levels of interleukin-17/interleukin-23 during acute rejection in liver transplantation. Liver Transpl. 15, 629-633.
  5. Friedman, B.H., Wolf, J.H., Wang, L., Putt, M.E., Shaked, A., Christie, J.D., Hancock, W.W., and Olthoff, K.M. (2012). Serum cytokine profiles associated with early allograft dysfunction in patients undergoing liver transplantation. Liver Transpl. 18, 166-176.
  6. Huang, W.H., Yan, Y., Li, J., De Boer, B., House, A.K., and Bishop, G.A. (2003). A short course of mycophenolate immunosuppression inhibits rejection, but not tolerance, of rat liver allografts in association with inhibition of interleukin-4 and alloantibody responses. Transplantation 76, 1159-1165.
  7. Ingelsten, M., Karlsson-Parra, A., Granqvist, A.B., Molne, J., Olausson, M., Haraldsson, B., and Nystrom, J. (2011). Postischemic inflammatory response in an auxiliary liver graft predicts renal graft outcome in sensitized patients. Transplantation 91, 888-894.
  8. Karakhanova, S., Oweira, H., Steinmeyer, B., Sachsenmaier, M., Jung, G., Elhadedy, H., Schmidt, J., Hartwig, W., Bazhin, A.V., and Werner, J. (2016). Interferon-gamma, interleukin-10 and interferon-inducible protein 10 (CXCL10) as serum biomarkers for the early allograft dysfunction after liver transplantation. Transpl. Immunol. 34, 14-24.
  9. Kim, C.H. (2009). Migration and function of Th17 cells. Inflamm Allergy Drug Targets 8, 221-228.
  10. Krishnan, A., Zhou, W., Lacey, S.F., Limaye, A.P., Diamond, D.J., and La Rosa, C. (2010). Programmed death-1 receptor and interleukin-10 in liver transplant recipients at high risk for late cytomegalovirus disease. Transpl. Infect Dis. 12, 363-370.
  11. Lee, B., Oh, C.K., Kim, M.S., Kim, J.H., Kim, S.J., Kim, H.S., and Shin, G.T. (2012). Cytokine gene expression in peripheral blood mononuclear cells during acute renal allograft rejection. Transplant Proc. 44, 236-240.
  12. Millan, O., Rafael-Valdivia, L., Torrademe, E., Lopez, A., Fortuna, V., Sanchez-Cabus, S., Lopez-Pua, Y., Rimola, A., and Brunet, M. (2013). Intracellular IFN-gamma and IL-2 expression monitoring as surrogate markers of the risk of acute rejection and personal drug response in de novo liver transplant recipients. Cytokine 61, 556-564.
  13. Millan, O., Rafael-Valdivia, L., San Segundo, D., Boix, F., Castro-Panete, M.J., Lopez-Hoyos, M., Muro, M., Valero-Hervas, D., Rimola, A., Navasa, M., et al. (2014). Should IFN-gamma, IL-17 and IL-2 be considered predictive biomarkers of acute rejection in liver and kidney transplant? Results of a multicentric study. Clin. Immunol. 154, 141-154.
  14. Nakagiri, T., Inoue, M., Minami, M., Shintani, Y., and Okumura, M. (2012). Immunology mini-review: the basics of T(H)17 and interleukin-6 in transplantation. Transplant Proc. 44, 1035-1040.
  15. Raschzok, N., Reutzel-Selke, A., Schmuck, R.B., Morgul, M.H., Gauger, U., Prabowo, K.A., Tannus, L.M., Leder, A., Struecker, B., Boas-Knoop, S., et al. (2015). CD44 and CXCL9 serum protein levels predict the risk of clinically significant allograft rejection after liver transplantation. Liver Transpl. 21, 1195-1207.
  16. Song, G.W., Lee, S.G., Hwang, S., Kim, K.H., Ahn, C.S., Moon, D.B., Ha, T.Y., Jung, D.H., Park, G.C., Kang, S.H., et al. (2014). Biliary stricture is the only concern in ABO-incompatible adult living donor liver transplantation in the rituximab era. J. Hepatol. 61, 575-582.
  17. Sreekumar, R., Rasmussen, D.L., Wiesner, R.H., and Charlton, M.R. (2002). Differential allograft gene expression in acute cellular rejection and recurrence of hepatitis C after liver transplantation. Liver Transpl. 8, 814-821.
  18. Tannapfel, A., Geissler, F., Witzigmann, H., Hauss, J., and Wittekind, C. (2001). Analysis of liver allograft rejection related genes using cDNA-microarrays in liver allograft specimen. Transplant Proc. 33, 3283-3284.
  19. Wang, Y., Zhang, M., Liu, Z.W., Ren, W.G., Shi, Y.C., Sun, Y.L., Wang, H.B., Jin, L., Wang, F.S., and Shi, M. (2014). The ratio of circulating regulatory T cells (Tregs)/Th17 cells is associated with acute allograft rejection in liver transplantation. PLoS One 9, e112135.
  20. Xu, C., Chen, X., Chang, C., Wang, G., Wang, W., Zhang, L., Zhu, Q., Wang, L., and Zhang, F. (2011). Analysis of gene expression profiles of liver stellate cells during liver regeneration in rats. Mol. Cells 31, 17-23.
  21. Xue, F., Higgs, B.W., Huang, J., Morehouse, C., Zhu, W., Yao, X., Brohawn, P., Xiao, Z., Sebastian, Y., Liu, Z., et al. (2015). HERC5 is a prognostic biomarker for post-liver transplant recurrent human hepatocellular carcinoma. J. Transl. Med. 13, 379.
  22. Zhou, Y., Yang, X., Zhang, H., and Jiang, J. (2015). The roles of T helper type 17/regulatory T cells in acute rejection after liver transplantation in rats. Transplantation 99, 1126-1131.

Cited by

  1. Cytokine profiles in Tibetan macaques following α-1,3-galactosyltransferase-knockout pig liver xenotransplantation vol.24, pp.5, 2017,
  2. The role of IL-23/IL-17 axis in human kidney allograft rejection pp.07415400, 2018,
  3. The impact of serum cytokines in the development of early allograft dysfunction in living donor liver transplantation vol.97, pp.16, 2018,